Tuesday Update for 2020-10-27 — 1 Comment

  1. The “to EUA or not to EUA” question probably is somewhat informed by the early termination of the ACTT trial of remdesivir (and issuance of an EUA). Although the trial showed that remdesivir reduced the length of hospital stays in patients on oxygen, the question of whether or not remdesivir actually would have saved lives — or maybe even increased mortality in some patients — couldn’t be answered without letting the trial run. And now we’ll probably never know, because giving remdesivir has become the de facto standard of care.


Leave a Reply

HTML tags allowed in your comment: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>